Estrogen replacement therapy and colon cancer: A clinical review

Journal of Women's Health and Gender-Based Medicine

Volumn 8, Issue 9, 1999, Pages 1155-1166

  Crandall, Carolyn J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ARTICLE; CANCER PREVENTION; COLON ADENOMA; COLON CANCER; COLON POLYP; COLORECTAL CANCER; ENDOSCOPY; ESTROGEN THERAPY; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; METHODOLOGY; POSTMENOPAUSE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0032725294     PISSN: 15246094     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1.1999.8.1155     Document Type: Article

References (44)

1. Potter JD. Hormones and colon cancer [Editorial; Comment]. Natl Cancer Inst 1995;87:1039.
2. Fraumeni JF Jr, Lloyd JW, Smith EM, Wagoner JK. Cancer mortality among nuns: Role of marital status in etiology of neoplastic disease in women. J Natl Cancer Inst 1969;42:455.
3. McMichael AJ, Potter JD. Reproduction, endogenous and exogenous sex hormones, and colon cancer: A review and hypothesis. J Natl Cancer Inst 1980;65:1201.
4. Cuzick J. Medicinal drugs with hormonal activity as chemopreventive agents. IARC Sci Publ 1996;270:99.
5. Potter JD, Bostick RM, Grandits GA, et al. Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: The Minnesota Cancer Prevention Research Unit Case-Control Study. Cancer Epidemiol Biomarkers Prev 1996;5:779.
6. Hébert-Croteau N. A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biomarkers Prev 1998;7:653.
7. MacLennan SC, MacLennan AH, Ryan P. Colorectal cancer and oestrogen replacement therapy. A meta-analysis of epidemiological studies. Med J Aust 1995; 162:491.
8. Newcomb PA, Storer BE, Marcus PM. Cancer of the large bowel in relation to use of hormone replacement therapy. Am J Epidemiol 1992;136:958.
9. Rosenberg L, Werler MM, Kaufman DW, Shapiro S. Cancers of the colon and rectum in relation to reproductive factors. Am J Epidemiol 1987;126:760.
10. Adami HO, Persson I, Hoover R, Schairer C, Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 1989;44:833.
11. Bostick RM, Potter JD, Kushi LH, et al. Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 1994;5:38.
12. Chute CG, Willett WC, Colditz GA, Stampfer MJ, Rosner B, Speizer FE. A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women [see Comments]. Epidemiology 1991;2:201.
13. Jacobson JS, Neugut AI, Garbowski GC, et al. Reproductive risk factors for colorectal adenomatous polyps (New York City, NY, United States). Cancer Causes Control 1995;6:513.
14. Peipins LA, Newman B, Sandler RS. Reproductive history, use of exogenous hormones, and risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 1997;6:671.
15. Grodstein F, Martinez ME, Platz EA, et al. Postmenopausal hormone use and risk for colorectal cancer and adenoma [see Comments]. Ann of Intern Med 1998;128:705.
16. Calle EE, Miracle-McMahill HL, Thun MJ, Heath CW Jr. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 1995;87: 517.
17. Persson I, Yuen J, Bergkvist L, Schairer C. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy - Long-term follow-up of a Swedish cohort. Int J Cancer 1996;67:327.
18. Davis FG, Furner SE, Persky V, Koch M. The influence of parity and exogenous female hormones on the risk of colorectal cancer. Int J Cancer 1989;43:587.
19. Fernandez E, La Vecchia C, D'Avanzo B, Franceschi S, Negri E, Parazzini F. Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer. Br J Cancer 1996;73:1431.
20. Fernandez E, La Vecchia C, Braga C, et al. Hormone replacement therapy and risk of colon and rectal cancer. Cancer Epidemiol Biomarkers Prev 1998;7:329.
21. Furner SE, Davis FG, Nelson RL, Haenszel W. A case-control study of large bowel cancer and hormone exposure in women. Cancer Res 1989;49:4936.
22. Gerhardsson de Verdier M, London S. Reproductive factors, exogenous female hormones, and colorectal cancer by subsite. Cancer Causes Control 1992;3:355.
23. Hammond CB, Jelovsek FR, Lee KL, Creasman WT, Parker RT. Effects of long-term estrogen replacement therapy. II. Neoplasia. Am J Obstet Gynecol 1979; 133:537.
24. Jacobs EJ, White E, Weiss NS. Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA). Cancer Causes Control 1994;5:359.
25. Kampman E, Potter JD, Slattery ML, Caan BJ, Edwards S. Hormone replacement therapy, reproductive history, and colon cancer: A multicenter, case-control study in the United States [see Comments]. Cancer Causes Control 1997;8:146.
26. Marcus PM, Newcomb PA, Young T, Storer BE. The association of reproductive and menstrual characteristics and colon and rectal cancer risk in Wisconsin women. Ann Epidemiol 1995;5:303.
27. Newcomb PA, Storer BE. Postmenopausal hormone use and risk of large-bowel cancer [see Comments] [published erratum appears in J Natl Cancer Inst 1995;87:1416]. J Natl Cancer Inst 1995;87:1067.
28. Peters RK, Pike MC, Chang WW, Mack TM. Reproductive factors and colon cancers. Br Cancer 1990; 61:741.
29. Potter JD, McMichael AJ. Large bowel cancer in women in relation to reproductive and hormonal factors: A case-control study. J Natl Cancer Inst 1983;71:703.
30. Talamini R, Franceschi S, Dal Maso L, et al. The influence of reproductive and hormonal factors on the risk of colon and rectal cancer in women. Eur J Cancer 1998;34:1070.
31. Weiss NS, Daling JR, Chow WH. Incidence of cancer of the large bowel in women in relation to reproductive and hormonal factors. J Natl Cancer Inst 1981; 67:57.
32. Wu-Williams AH, Lee M, Whittemore AS, et al. Reproductive factors and colorectal cancer risk among Chinese females. Cancer Res 1991;51:2307.
33. Burch JC, Byrd BF, Vaughn WK. The effects of long-term estrogen administration to women following hysterectomy. Front Horm Res 1975;3:208.
34. Folsom AR, Mink PJ, Sellers TA, Hong CP, Zheng W, Potter JD. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health 1995; 85:1128.
35. Risch HA, Howe GR. Menopausal hormone use and colorectal cancer in Saskatchewan: A record linkage cohort study. Cancer Epidemiol Biomarkers Prev 1995;4:21.
36. Troisi R, Schairer C, Chow WH, Schatzkin A, Brinton LA, Fraumeni JF Jr. A prospective study of menopausal hormones and risk of colorectal cancer (United States) [see Comments]. Cancer Causes Control 1997;8:130.
37. Wu AH, Paganini-Hill A, Ross RK, Henderson BE. Alcohol, physical activity and other risk factors for colorectal cancer: A prospective study. Br J Cancer 1987;55:687.
38. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM. Estrogen replacement therapy II: A prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol 1979;54:74.
39. Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: A review and meta-analysis. Am J Med 1999;106:574.
40. Potter JD, Slattery ML, Bostick RM, Gapstur SM. Colon cancer: A review of the epidemiology. Epidemiol Rev 1993;15:499.
41. Calafi Alsina J. Benefits of hormone replacement therapy - Overview and update. Int J Fertil Womens' Med 1997;42(Suppl 2):329.
42. English MA, Kane KF, Cruickshank N, Langman MJ, Stewart PM, Hewison M. Loss of estrogen inactivation in colonic cancer. J Clin Endocrinol Metab 1999; 84:2080.
43. La Vecchia C, Franceschi S. Reproductive factors and colorectal cancer. Cancer Causes Control 1991;2:193.
44. Potter JD, Bigler J, Fosdick L, et al. Colorectal adenomatous and hyperplastic polyps: Smoking and N-acetyltransferase 2 polymorphisms. Cancer Epidemiol Biomarkers Prev 1999;8:69.